Atorvastatin Calcium Tablet
Product Images NDC 71335-1929

6 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-1929). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)
Chemical structure of Atorvastatin Calcium with notation indicating two molecules and calcium ion with three water molecules of hydration (Ca2+ · 3H2O). The diagram shows the molecular framework typical of atorvastatin.*
FDA Label Image

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)
A line graph depicting cumulative incidence (%) over a period of 3.5 years comparing Atorvastatin and placebo. Atorvastatin shows a lower cumulative incidence compared to placebo throughout the timeline. The graph includes a hazard ratio (HR=0.64) with confidence interval (0.50-0.83) and a p-value of 0.0005.*
FDA Label Image

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)
A line graph comparing cumulative hazard percentages over four years between placebo and atorvastatin groups. The x-axis represents time to first primary endpoint through four years of follow-up in years, and the y-axis shows cumulative hazard percentage. Two lines show lower hazard in the atorvastatin group compared to placebo, with a hazard ratio (HR) of 0.63 and p-value of 0.001.*
FDA Label Image

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over five years. The graph shows two groups: Atorvastatin 10 mg and Atorvastatin 80 mg, with the higher dose group consistently having a slightly lower event rate. The hazard ratio (HR) and p-value indicate statistical analysis results.*
FDA Label Image

Label (Lbl713351929)

Label (Lbl713351929)
Atorvastatin Calcium Tablets, USP 20 mg oral tablets label by Bryant Ranch Prepack. The label shows the product name, strength (20 mg), quantity (30 tablets), and the NDC number 71335-1929-01. It includes storage instructions and a barcode, with the Bryant Ranch Prepack logo (BRP Pharmaceuticals). The label is marked Rx only.*
FDA Label Image

Label (Lbl7133519292)

Label (Lbl7133519292)
Atorvastatin Calcium 20 mg tablet packaging label by Bryant Ranch Prepack. The label includes storage instructions to keep in a light-resistant container at 20-25°C (68-77°F). It shows a comparison to Lipitor 20 mg tablet by Lupin Limited, with a package count of 30 tablets and features a barcode and lot number 1523487.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.